(Reuters) -Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized ...

This isn’t about managing the AIDS pandemic. It’s about ending it — and letting a new generation grow and thrive free of its ...

Devastating funding cuts from international donors are hitting countries hardest affected by HIV — but many are showing ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Only 17,000 Ugandans to benefit from $1.1m Global Fund support as officials warn of high demand for long-acting prevention ...

Global Fund notes that the US has contributed more than $26.31 billion to date and pledged up to $6 billion for the Seventh ...

The Senate will be voting on a Trump-proposed rescissions package July 18. The package aims to cut funding for foreign aid already appropriated for years by a bipartisan Congress. Included is The ...

A pivotal moment in the fight to end AIDS -- ensuring lifesaving innovation reaches those who need it most, wherever they liveThe Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) ...

Canada, he says, should double its funding to the Global Fund — the international organization that distributes funds ...

DAR ES SALAAM: TANZANIA National Coordinating Mechanism (TNCM) has reaffirmed its commitment to ensure the Global Fund ...

Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).